ArticleMolecular medicine (Cambridge, Mass.)2026

A novel CD112-derived peptide targeting gut-primed neutrophils to attenuate deadly hepatic injury.

Takayuki Kato et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.